NASH Emerging Therapies: A New Era in Nonalcoholic Steatohepatitis Treatment Nonalcoholic Steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and liver damage caused by fat accumulation, not alcohol consumption. It represents a significant health challenge, often leading to cirrhosis, liver failure, and an increased risk of hepatocellular carcinoma....
NASH: The Stealthy Epidemic Affecting Millions
Nonalcoholic Steatohepatitis : Highly Epidemic Nonalcoholic Steatohepatitis represents a significant and escalating health crisis globally, characterized by liver inflammation and damage not associated with excessive alcohol consumption. As a severe form of nonalcoholic fatty liver disease (NAFLD), NASH is a major concern due to its potential to progress to advanced...
Meeting the Unmet Need: Tackling Nonalcoholic Steatohepatitis (NASH)
Meeting the Unmet: Nonalcoholic Steatohepatitis (NASH) Nonalcoholic Steatohepatitis (NASH) is a chronic liver disease characterized by inflammation and damage caused by fat buildup in the liver. Unlike other liver conditions, NASH is not associated with alcohol consumption, making it a unique and challenging public health issue. The disease can progress...
Innovative Approaches: Nucleic Acids and Gene Therapies in Neuromuscular Disorders
Nucleic Acids and Gene Therapies in Neuromuscular Disorders: Next-Generation Therapeutic Strategies Neuromuscular disorders (NMDs) encompass a broad range of conditions that primarily affect the nerves controlling voluntary muscles, resulting in muscle weakness, degeneration, and disability. Among these, Duchenne muscular dystrophy (DMD) is one of the most severe, characterized by rapid...